Evidence for a Role of Transporter-Mediated Currents in the Depletion of Brain Serotonin Induced by Serotonin Transporter Substrates-Reference-Cited by-同舟云学术

Evidence for a Role of Transporter-Mediated Currents in the Depletion of Brain Serotonin Induced by Serotonin Transporter Substrates

Published:2013-11-28 Issue:6 Volume:39 Page:1355-1365
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Baumann Michael H,Bulling Simon,Benaderet Tova S,Saha Kusumika,Ayestas Mario A,Partilla John S,Ali Syed F,Stockner Thomas,Rothman Richard B,Sandtner Walter,Sitte Harald H

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/npp2013331.pdf

Reference69 articles.

1. Adams SV, Defelice LJ (2003). Ionic currents in the human serotonin transporter reveal inconsistencies in the alternating access hypothesis. Biophys J 85: 1548–1559.

2. Appel NM, Mitchell WM, Contrera JF, De Souza EB (1990). Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography. Synapse 6: 33–44.

3. Auerbach SB, Kamalakannan N, Rutter JJ (1990). TFMPP and RU24969 enhance serotonin release from rat hippocampus. Eur J Pharmacol 190: 51–57.

4. Baumann MH, Ayestas MA, Dersch CM, Rothman RB (2001). 1-(M-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain. Neuropsychopharmacology 24: 492–501.

5. Baumann MH, Ayestas MA, Partilla JS, Sink JR, Shulgin AT, Daley PF et al (2012). The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37: 1192–1203.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allosteric Inhibition and Pharmacochaperoning of the Serotonin Transporter by the Antidepressant Drugs Trazodone and Nefazodone;Molecular Pharmacology;2024-05-20

2. Effect of Hepatic Impairment on the Pharmacokinetics of Fenfluramine and Norfenfluramine;The Journal of Clinical Pharmacology;2024-03-25

3. Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome;Epilepsia Open;2023-12-22

4. Convolamine, a tropane alkaloid extracted from Convolvulus plauricalis, is a potent sigma‐1 receptor‐positive modulator with cognitive and neuroprotective properties;Phytotherapy Research;2023-11-27

5. The Important Role of Transporter Structures in Drug Disposition, Efficacy, and Toxicity;Drug Metabolism and Disposition;2023-06-09